International Isotopes, Inc. engages in the manufacture of nuclear medicine calibration and reference standards cobalt tele therapy sources, as well as radioisotopes and radiochemical for medical research and clinical devices. The company is headquartered in Idaho Falls, Idaho and currently employs 41 full-time employees. The firm's segments include Theranostics Products, Cobalt Products, Nuclear Medicine Standards, Medical Device Products and Fluorine Products. Theranostics Products segment includes production and distribution of its generic sodium iodide I-131 drug product for the treatment of hyperthyroidism and carcinoma of the thyroid. Cobalt Products segment includes the production of bulk cobalt (cobalt-60), fabrication of cobalt capsules for radiation therapy and various industrial applications. Nuclear Medicine Standards segment consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) imaging. Fluorine Products segment is involved in the production of small-scale qualification samples of high-purity fluoride gas for various industrial applications. The company is working to launch the RadVent brand of medical devices.
Follow-Up Questions
Tỷ lệ P/E của International Isotopes Inc (INIS) là bao nhiêu?
Tỷ lệ P/E của International Isotopes Inc là N/A
Hiệu suất giá của cổ phiếu INIS như thế nào?
Giá hiện tại của INIS là 0.0599, đã decreased 0% trong ngày giao dịch cuối cùng.
Vốn hóa thị trường của International Isotopes Inc là bao nhiêu?
Vốn hóa thị trường hiện tại của International Isotopes Inc là $31.6
Có nên mua, bán hay nắm giữ International Isotopes Inc?
Theo các nhà phân tích phố Wall, 0 nhà phân tích đã đưa ra xếp hạng phân tích cho International Isotopes Inc, bao gồm 0 mua mạnh, 0 mua, 0 nắm giữ, 0 bán, và 0 bán mạnh